Peter Jackson Email & Phone Number

Wellesley, MA, US

Pioneered the launch and continued leadership of this business dedicated to serving as a trusted advisor and subject matter expert to new and emerging medical device and biotechnology companies, with a focus on providing guidance and direction in the areas of commercialization, business development and licensing, capital raises, business plans.

Zurich, Zurich, CH

Developing towards commercialization an exciting new technology which acts against fibrosis associated with implantable devices. The technology is currently adapted for cardiac implantable devices and breast implants.

Maintained accountability for the success of operations in Europe for this provider of data-driven consulting services to clients in the pharmaceutical and biotechnology verticals. Leverages the use of primary and secondary data, coupled with deep industry insight, to drive the development of evidence-based recommendations for commercial and pre-commercial.

Baillargues, Hérault, FR

Led vision, strategy, and execution for all facets of operations at this clinical stage pharmaceutical company that focuses on metal ion therapeutics and metal decorporation agents using disruptive drug delivery formulations. Served a key role in business development and the development of strategic alliances, directly impacting revenue.* Contributed to.

Almere, NL

Fulfilled a critical role driving revenue for the largest, independently owned pan-European mass spectrometry support company, with authority over a team of sales professionals charged with increasing penetration into UK, France, and Germany markets and eroding the share of key competitors. Responsible for all commercial and marketing activities, reporting.

Milford, MA, US

Directed marketing strategy and execution across Europe and India for this US-based analytical instrumentation corporation, with accountability for the success of a team of field marketing professionals and marketing communication specialists securing increased visibility in the Pharma and Proteomics markets.* Recognized for implementing a strategy to.

Suresnes, FR

Heading a team of scientists that were involved in both discovery and development drug metabolism studies. Implementation of novel in vitro technologies for the prediction of metabolic fate, enzyme induction and drug-drug interactions in human. Lead the drug metabolism project for Valdoxan® and Ivabradine®.

Suresnes, FR

Responsible for implementation of novel mass spectrometry technologies for use within the drug metabolism department. Study Director responsible for a team of technicians performing GLP in vivo and in vitro drug metabolism studies.

Bachelor'S Degree, Chemistry

Phd, Analytical Chemistry